Clinical Operations

Clinical Execution Breaks Down When Systems and Data Fall Short

Clinical operations are no longer held together by manual coordination and end-of-study cleanup. They now depend on connected systems, reliable data, and continuous oversight. We help teams adapt their operating models to this new reality.

Trusted by some of the leading Life Science organizations
Novo Nordisk
Sobi
Zealand Pharma
Vetter Pharma
Syndax
Orifarm
Nxera
Medac
Lundbeck
Prilenia
Karo healthcare
Gilead
Genmab
Fujifilm
Ferring Pharmaceuticals
BeOne
AOP Health
Novo Nordisk
Sobi
Zealand Pharma
Vetter Pharma
Syndax
Orifarm
Nxera
Medac
Lundbeck
Prilenia
Karo healthcare
Gilead
Genmab
Fujifilm
Ferring Pharmaceuticals
BeOne
AOP Health

What effective clinical operations look like

Clear, continuous oversight

Clinical leaders have a reliable view of trial progress across systems, vendors, and regions. Oversight is driven by trusted data rather than manual reconciliation.

Fewer handoffs and less rework

Aligned systems and governed data reduce duplicate tracking, offline workarounds, and end-of-study cleanup. Teams spend less time fixing inconsistencies and more time progressing studies.

TMF aligned with execution

TMF completeness and quality improve naturally as milestones, documents, and metadata stay in sync throughout study execution, not corrected under inspection pressure.

AI that supports execution

With clean data and clear governance, AI can automate routine checks, surface risk earlier, and support teams without introducing new complexity or compliance uncertainty.

Testimonials

Hear from our clients

Practical results delivered through deep life science expertise.

"What stands out about Epista is the combination of technical and business insight, delivered by people who are approachable and great to work with."

Swedish Pharma company

"Working with Epista has been a game-changer. They’re able to understand what we’re trying to achieve – even when we struggle to define it clearly ourselves. Their consultants have the insight and experience to turn our needs into system solutions that actually support how we work. That’s the kind of partner you want."

Swedish Pharma company

"What really sets Epista apart is that they don’t behave like external consultants – they integrate seamlessly into our team, bringing high energy, dedication, and creativity. We’ve consistently felt prioritized and supported, even when new needs arise or changes are needed."

Large Danish Pharma company

"We are very satisfied with our new IT QMS. It has been hard work for the whole department, but also very engaging and has given us a great foundation for our documentation. We appreciate all the work that Karin and Epista have done for us."

“The collaboration with Epista can be described as very pleasant, constructive and productive. Their experience and knowledge forces us to challenge our requirements which results in realistic solutions that add real value to the business.”

Bilthoven Biologicals

“Having completed the project, I can confidently say it was in safe hands. Epista’s knowledgeable resources and extensive experience with similar projects proved invaluable.”

Man with curly blond hair and striped shirt sitting at a table with a laptop, smiling and looking to the side in a modern office environment.
Why Epista

Why life science companies choose Epista

Built for clinical execution

Our consultants come from clinical operations, TMF, and clinical systems roles. They understand the pressure of running active studies, coordinating CROs, and maintaining oversight while timelines move.

Deep system expertise with a practical lens

We work across leading clinical platforms including CTMS, eTMF, and oversight tools. Our focus is on making systems work together in practice, not as isolated implementations.

Data-first approach to modernization and AI

Data readiness and governance sit at the center of everything we do. Without trusted data, system optimization, and AI initiatives stall or create new risk.

Execution-focused partnership

We do the work teams do not have capacity for while studies are running. The goal is not future-state slide decks, but clinical operations that perform better study after study.